Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 144 of 6351
-
Massive new study aims to outsmart childhood leukemia
Disease control Recruiting nowALLTogether collects the experience of previously successful treatment of infants, children and young adults, with ALL from a number of well-renowned study groups into a new master protocol, which is both a comprehensive system for stratification and treatment of ALL in this age-…
Phase 3 • Sponsor: Mats Heyman • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Hope for pancreatic cancer prevention: old drug, new trial
Prevention OngoingThis is a multi-center randomized double-blind placebo controlled trial of patients with high-risk intraductal papillary mucinous neoplasms (IPMNs) of the pancreas. The primary objective is to evaluate the effect of sulindac on the presence or absence of progression of IPMN after…
Phase 2 • Sponsor: Duke University • Aim: Prevention
Last updated Sep 10, 2026 00:00 UTC
-
Engineered stem cells aim to speed recovery in blood cancer patients
Disease control CompletedOmidubicel is an investigational therapy for patients with high-risk hematologic malignancies.
Phase 3 • Sponsor: Gamida Cell ltd • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Could this pill help kids with biliary atresia skip a liver transplant?
Disease control CompletedDouble-blind, randomized, placebo-controlled, Phase 3 study to investigate the efficacy and safety of odevixibat compared to placebo in children with biliary atresia who have undergone a Kasai hepatoportoenterostomy.
Phase 3 • Sponsor: Albireo, an Ipsen Company • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Hidden heart rhythm problems after stroke: can longer monitoring prevent a second stroke?
Prevention OngoingPatients who have suffered a stroke are having an increased risk of having recurrent stroke in the future. This risk of stroke is increased by atrial fibrillation, which often "comes and goes" (called paroxysmal) and hence escapes routine diagnostics. The hypothesis of Find-AF 2 …
Sponsor: University of Leipzig • Aim: Prevention
Last updated Aug 30, 2026 00:00 UTC
-
Promising drug cocktail aims to eradicate hidden breast cancer cells
Disease control Recruiting nowThe purpose of this study is to determine if a combination of two drugs sacituzumab govitecan and atezolizumab works as a treatment for residual cancer in the breast or lymph nodes and have circulating tumor DNA in the blood. This research study involves the following investigat…
Phase 2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Can AI hear heart defects in children? a large trial puts it to the test
Diagnosis CompletedThe objective of this study is to establish AI algorithm based on the deep learning to strengthen the ability to classify the heart murmurs of healthy people and different major or other subdivided congenital heart diseases(CHDs) and to evaluate the effectiveness of artificial in…
Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Diagnosis
Last updated Aug 05, 2026 00:00 UTC
-
Promising immunotherapy combo takes on advanced liver cancer
Disease control OngoingThis is a prospective, randomized, placebo-controlled, double-blind, multicenter phase III registration clinical study to observe, compare and evaluate the efficacy and safety of Toripalimab combined with Lenvatinib versus placebo combined with Lenvatinib as the 1st-line therapy …
Phase 3 • Sponsor: Shanghai Junshi Bioscience Co., Ltd. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Can a glimpse of the eye reveal What's happening in the lungs?
Diagnosis Recruiting nowThis study intends to collect ophthalmologic examination results, pulmonary examination results and related indexes from patients with pulmonary disease and control populations, and combine big data analysis and artificial intelligence technology to explore whether new methods ca…
Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University • Aim: Diagnosis
Last updated Aug 14, 2026 00:00 UTC
-
Can new drug cocktails reawaken the immune system against melanoma?
Disease control CompletedSubstudy 02A is part of a larger research study that is testing experimental treatments for melanoma, a type of skin cancer. The larger study is the umbrella study. The goal of substudy 02A is to evaluate the safety and efficacy of investigational treatment arms in participants …
Phase 1/2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Promising combo aims to stop smoldering myeloma in its tracks
Disease control OngoingPrimary Objectives: * Safety run-in Part: To confirm the recommended dose of isatuximab when combined with lenalidomide and dexamethasone in participants with high-risk smoldering multiple myeloma (SMM) * Randomized Phase 3 Part: To demonstrate the clinical benefit of isatuximab…
Phase 3 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Massive ALS trial tests multiple drugs at once to find a way to slow the deadly disease
Disease control OngoingThe HEALEY ALS Platform Trial is a perpetual multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of ALS.
Phase 2/3 • Sponsor: Merit E. Cudkowicz, MD • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
CAR-T therapy takes on standard drugs in Late-Stage myeloma trial
Disease control OngoingThe purpose of this study is to compare the efficacy of ciltacabtagene autoleucel (cilta-cel) with standard therapy, either Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexamethasone (DPd).
Phase 3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can a new drug shrink Hard-to-Treat lymphoma tumors?
Disease control CompletedThis is an open,single-arm,multicenter phase II clinical study to evaluate the efficacy and safety of BEBT-908 for injection in the treatment of relapsed or refractory diffuse large B-cell lymphoma. The study will be divided into two stages: phase Ⅱa and phase Ⅱb. Phase Ⅱa is an …
Phase 2 • Sponsor: BeBetter Med Inc • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Gene therapy heals wounds in rare skin disease?
Disease control OngoingThe purpose of this study is to determine whether administration of FCX-007 in addition to standard of care improves wound healing as compared to standard of care alone (control) in children, adolescents, and adults with Recessive Dystrophic Epidermolysis Bullosa. Funding Source…
Phase 3 • Sponsor: Castle Creek Biosciences, LLC. • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New lung cancer drug aims to outperform chemotherapy in Late-Stage trial
Disease control CompletedA Phase 3 Study to Compare AMG 510 with Docetaxel in Non Small Cell Lung Cancer (NSCLC) subjects with KRAS p. G12c mutation
Phase 3 • Sponsor: Amgen • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Immune cells take on deadly childhood brain cancer
Disease control Recruiting nowThe primary purpose of this study is to test whether CAR T cells targeting GD2 (GD2CART) can be successfully made and safely given to children and adults with H3K27M-mutant diffuse midline glioma (DMG). Eligible subjects may have DMG arising in the pons (called difuse intrinisic …
Phase 1 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
Radiation before surgery may boost chemo for Stomach-Esophagus cancer
Disease control CompletedThis is a multicenter, prospective, randomized, stratified, controlled, open-label study comparing neoadjuvant radiochemotherapy with FLOT versus FLOT chemotherapy alone für patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction (GE…
Phase 3 • Sponsor: Universitätsmedizin Mannheim • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Engineered immune cells take on tough leukemia in new trial
Disease control OngoingThis is a Phase 1b/2 study to evaluate the safety and efficacy of autologous T cells engineered with a chimeric antigen receptor (CAR) targeting CD19 in adult patients with relapsed or refractory (r/r) B cell acute lymphoblastic leukemia (ALL).
Phase 1/2 • Sponsor: Autolus Limited • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Can a simple inhaled combo keep pneumonia patients off ventilators?
Disease control Stopped earlyThis research study seeks to establish the effectiveness of a combination of an inhaled corticosteroid and a beta agonist compared to placebo for the prevention of acute respiratory failure (ARF) in hospitalized patients with pneumonia and hypoxemia.
Phase 3 • Sponsor: Stanford University • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC